Skip to content
BOLUS
Subscribe

Signal from the log

Vitroscope

5 M$ · Seed · Norway · Biotech

Vitroscope, en Norvège, fait vivre des tissus humains plusieurs jours hors du corps en y faisant circuler un liquide sous oxygène, pH et température contrôlés, pour suivre la réponse aux médicaments. Sa levée de seed s'accompagne de 2 M$ non dilutifs du Research Council of Norway.

Verified

Announced on , logged by the watch of 3 November 2026.

Operation
Funding round
Announced amount
5 M$
Stage
Seed
Country
Norway
Sector
Biotech

What the log says

Editorial note, in French

Communiqué ouvert, montant relu et fonds nommés.

The investors

Led by Cerberus Ventures , YZR Capital , with Arcas Ventures , Golden Egg Check , Devico Invest

Provenance
Logged on 3 November 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.

One address, nothing else.

One letter a week, on Fridays: the week's funding rounds, the funds named, the amounts double checked. The list is never sold, one click to unsubscribe. The letter is written in French.

You are, if you care to say

Email confirmation before any subscription. The list is never sold. What Bolus knows about you is written on the privacy page (in French).